Peripartum cardiomyopathy (PPCM) is a disease that predominantly affects Black African women. The history of peripartum cardiac failure in Africa dates to the 1960s, before the availability of echocardiography. With the availability of echocardiography in the late 1970s, studies on well-characterised PPCM began to be reported. To date, there is no population-based PPCM study in Africa. However, hospital-based studies have reported incidence rates as high as 1:100 deliveries in Nigeria and representing up to 52% of all cardiomyopathies. For reasons that are not yet very clear, there are obvious wide disparities in incidence and prevalence within and between African Countries. Likewise, prevalence of suggested risk factors for the disease var...
AIMS AND OBJECTIVES OF THE STUDY: To study the incidence, assess the risk factors and study the cl...
BACKGROUND: Cardiomyopathies, defined as diseases involving mainly the heart muscles, are linked to ...
Aims We sought to describe the clinical presentation, management, and 6-month outcomes in women wit...
peer-reviewedPeripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute ...
Aims: The prospective, multicentre Peripartum Cardiomyopathy in Nigeria (PEACE) registry originally ...
Aims: The aim of this study was to describe the incidence, clinical characteristics and risk factors...
Master of Medical Sciences in Medical Biology. University of KwaZulu-Natal. Durban, 2015.Introductio...
Peripartum cardiomyopathy (PPCM) is a rare clinical entity during pregnancy. PPCM is a diagnosis of ...
Peripartum cardiomyopathy (PPCM) is a rare and potentially fatal form of systolic heart failure whic...
Cardiomyopathies are forms of disease in which the heart muscle is structurally and functionally abn...
Background—Cardiomyopathy, an often irreversible form of heart muscle disease that is associated wit...
ObjectivesThe purpose of this study was to assess whether African-American women are at increased ri...
Background: Peripartum cardiomyopathy (PPCM) is an incompletely understood disease that causes signi...
Aims: The purpose of this study is to describe disease presentation, co-morbidities, diagnosis and ...
Introduction: Peripartum cardiomyopathy (PPCM) is a form of unexplained heart failure associated wit...
AIMS AND OBJECTIVES OF THE STUDY: To study the incidence, assess the risk factors and study the cl...
BACKGROUND: Cardiomyopathies, defined as diseases involving mainly the heart muscles, are linked to ...
Aims We sought to describe the clinical presentation, management, and 6-month outcomes in women wit...
peer-reviewedPeripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute ...
Aims: The prospective, multicentre Peripartum Cardiomyopathy in Nigeria (PEACE) registry originally ...
Aims: The aim of this study was to describe the incidence, clinical characteristics and risk factors...
Master of Medical Sciences in Medical Biology. University of KwaZulu-Natal. Durban, 2015.Introductio...
Peripartum cardiomyopathy (PPCM) is a rare clinical entity during pregnancy. PPCM is a diagnosis of ...
Peripartum cardiomyopathy (PPCM) is a rare and potentially fatal form of systolic heart failure whic...
Cardiomyopathies are forms of disease in which the heart muscle is structurally and functionally abn...
Background—Cardiomyopathy, an often irreversible form of heart muscle disease that is associated wit...
ObjectivesThe purpose of this study was to assess whether African-American women are at increased ri...
Background: Peripartum cardiomyopathy (PPCM) is an incompletely understood disease that causes signi...
Aims: The purpose of this study is to describe disease presentation, co-morbidities, diagnosis and ...
Introduction: Peripartum cardiomyopathy (PPCM) is a form of unexplained heart failure associated wit...
AIMS AND OBJECTIVES OF THE STUDY: To study the incidence, assess the risk factors and study the cl...
BACKGROUND: Cardiomyopathies, defined as diseases involving mainly the heart muscles, are linked to ...
Aims We sought to describe the clinical presentation, management, and 6-month outcomes in women wit...